Evaluated Therapy | Baseline (Mean + SD) | At 24 wks (Mean + SD) | % Change | p-value (Stat Sig.) | ||||
CAP (dB/m) | LSM (Kpa) | CAP (dB/m) | LSM(Kpa) | CAP | LSM | CAP | LSM | |
Lifestyle intervention (n=35) | 273.1 + 61.9 | 16.9 + 14.9 | 266.1 + 53.5 | 16.1 + 14.3 | -2.6 % | -4.9 % | >0.05 (NS) |
>0.05 (NS) |
Vit E (n=80) | 305.3 + 44.6 | 7.3 + 4.5 | 287.1 + 37.5 | 6.7 + 6.5 | -5.9 % | -8.3% | <0.001 (HS) | >0.05 (NS) |
Saroglitazar (n=68) | 312.8 + 43.3 | 12.3 + 7.9 | 278.8 + 49.3 | 9.8 + 5.6 | -10.9 % | -20.2 % | <0.001 (HS) | <0.001 (HS) |